FMA
ZYNE

FNY Managed Accounts’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

FNY Managed Accounts’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-7,500
Closed -$127K – 676
2017
Q2 		$127K Sell
7,500
-1,500
-17% -$25.4K 1.28% 25
2017
Q1 		$180K Buy
+9,000
New +$180K 0.56% 27